Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Biol Psychiatry. 2012 Oct 11;73(10):10.1016/j.biopsych.2012.09.007. doi: 10.1016/j.biopsych.2012.09.007

Figure 1. Immune Cell Parameters in Schizophrenia by Clinical Status.

Figure 1

Effect size estimates and 95% CIs for immune cell parameters in cross-sectional studies of acute relapse of psychosis (AR) and drug-naive first-episode psychosis (FEP) versus controls are represented by red and blue bars and error bars, respectively. For AR and FEP, positive effect sizes (bars going to the right) indicate that the parameter was higher in schizophrenia than controls; negative effect sizes (bars going to the left) indicate that levels were higher in controls than in patients with schizophrenia. Similarly, green bars and error bars represent effect size estimates and 95% CIs for the change in levels of immune parameters in longitudinal studies following antipsychotic treatment for an acute exacerbation of psychosis. Positive effect sizes (bars going to the right) indicate that the parameter increased following antipsychotic treatment for acute psychosis; negative effect sizes (bars going to the left) mean that the parameter decreased following antipsychotic treatment. Error bars that exclude 0 are significant at the p<0.05 level.